CD8+ T cells have the potential to eliminate cancer cells following recognition of cancer-specific and cancer-associated epitopes presented in human leukocyte antigen class I (HLA-I)-molecules on the cell surface of cancer cells (1, 2). Here, CD8A is linked to cancer.